Wall Street Zen Upgrades Healthpeak Properties (NYSE:DOC) to "Hold"

Key Points

• Wall Street Zen upgraded Healthpeak Properties (NYSE:DOC) from a "sell" rating to a "hold" in a note to investors.
• Analyst consensus is an average "Hold" rating with a $19.19 average price target, after mixed actions including Jefferies and Citigroup cutting targets and a split of six Buys versus eight Holds.
• Healthpeak beat Q4 estimates with $0.47 EPS (vs. $0.45) and $719.4M revenue, set FY2026 EPS guidance of 1.700–1.740, and is 93.57% institutionally owned with several large managers increasing positions.

Healthpeak Properties (NYSE:DOC - Get Free Report) was upgraded by stock analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a note issued to investors on Saturday.

DOC has been the subject of several other reports. Wells Fargo & Company reiterated a "positive" rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Citigroup cut their price target on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating for the company in a report on Wednesday, April 1st. Jefferies Financial Group lowered Healthpeak Properties from a "buy" rating to a "hold" rating and cut their price target for the stock from $21.00 to $17.00 in a report on Monday, December 15th. Cantor Fitzgerald set a $17.00 price target on Healthpeak Properties in a report on Monday, January 5th. Finally, Weiss Ratings upgraded Healthpeak Properties from a "sell (d+)" rating to a "hold (c-)" rating in a report on Monday, January 26th. Six investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and an average price target of $19.19.

Healthpeak Properties Price Performance

NYSE:DOC opened at $16.76 on Friday. The business's 50-day moving average price is $17.01 and its 200 day moving average price is $17.39. The firm has a market cap of $11.65 billion, a P/E ratio of 167.57, a PEG ratio of 8.93 and a beta of 1.10. Healthpeak Properties has a 52-week low of $15.71 and a 52-week high of $19.68. The company has a quick ratio of 2.82, a current ratio of 2.82 and a debt-to-equity ratio of 1.21.

Healthpeak Properties (NYSE:DOC - Get Free Report) last released its earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.45 by $0.02. The firm had revenue of $719.40 million for the quarter, compared to analyst estimates of $685.14 million. Healthpeak Properties had a return on equity of 0.84% and a net margin of 2.52%.Healthpeak Properties's revenue was up 3.1% compared to the same quarter last year. During the same period in the previous year, the company earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, sell-side analysts predict that Healthpeak Properties will post 1.86 earnings per share for the current fiscal year.

Institutional Trading of Healthpeak Properties

A number of institutional investors and hedge funds have recently modified their holdings of the company. State Street Corp increased its position in shares of Healthpeak Properties by 1.8% during the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust's stock valued at $947,889,000 after purchasing an additional 895,460 shares during the period. JPMorgan Chase & Co. increased its position in shares of Healthpeak Properties by 8.6% during the fourth quarter. JPMorgan Chase & Co. now owns 30,674,812 shares of the real estate investment trust's stock valued at $493,251,000 after purchasing an additional 2,438,278 shares during the period. Fuller & Thaler Asset Management Inc. increased its position in shares of Healthpeak Properties by 19.2% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock valued at $476,744,000 after purchasing an additional 4,776,056 shares during the period. Geode Capital Management LLC increased its position in shares of Healthpeak Properties by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 19,534,041 shares of the real estate investment trust's stock valued at $312,959,000 after purchasing an additional 123,274 shares during the period. Finally, Invesco Ltd. increased its position in shares of Healthpeak Properties by 9.9% during the fourth quarter. Invesco Ltd. now owns 18,298,776 shares of the real estate investment trust's stock valued at $294,244,000 after purchasing an additional 1,648,012 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.